Pharmafile Logo
Pharmafocus logo
Advanced Search
backlit_keyboard

Russia is spreading lies about COVID-19 vaccines, alleges UK Chief of Defence Staff

October 1, 2020
Research and Development Hackers, Russia, Russians, coronavirus vaccine

Russia is sowing disinformation about COVID-19 vaccines to undermine inoculation efforts in Western aligned countries, according to a top UK …

News
800px-library_of_congress_open_house_2182091

High US drug prices driven by profits, House Oversight Committee report finds

October 1, 2020
Research and Development

The rising cost of US drugs are primarily driven by the pursuit of profit by pharmaceutical companies, according to an …

News
nice_new_london_office_internal_3_web

NICE gives go-ahead for Sandoz’s Rizmoic to treat opioid-induced constipation

September 30, 2020
Research and Development, Sales and Marketing NHS, NICE, Rizmoic, Sandoz, UK

The National Institute for Health and Care Excellence (NICE) has recommended Sandoz’s Rizmoic (naldemedine) for the treatment of opioid-induced constipation …

News
bel-n-garijo-large

Company veteran Belén Garijo named as Merck KGaA’s first-ever female CEO

September 30, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck KGaA

German pharma firm Merck KGaA has taken the decision to appoint its first female Chief Executive Officer in its 352-year …

News
800px-a_tamiflu_oseltamivir_capsule

Judge allows $1.5 billion Tamiflu stockpiling lawsuit against Roche to go ahead

September 30, 2020
Research and Development Roche, Tamiflu

A Maryland federal judge denied Roche’s motion to throw out a lawsuit that alleges the company defrauded the US and …

News
amoeba

Brain-eating amoeba in Texas water supply kills six-year-old

September 30, 2020
Research and Development amoeba, brain eating ameoba

Officials in Texas have said it could take two to three months to disinfect the water supply in Lake Jackson …

News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

September 30, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten

The coronavirus news this week focuses on the development of treatments to alleviate symptoms of the virus, as Australian biotech …

News
pharmafocus_october_2020

The October 2020 issue of Pharmafocus is available to read free online now!

September 29, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020, October 2020, Pharmafocus, digital edition, pharma

The latest monthly edition of Pharmafocus is available to read for free online now! As the US sails past the …

News
reblozyl

Canadian approval for Reblozyl for transfusion-dependent anaemia in beta-thalassemia patients

September 29, 2020
Manufacturing and Production, Sales and Marketing BMS, Canada, Reblozyl

Bristol Myers Squibb and Acceleron have managed to secure regulatory approval in Canada for Reblozyl (luspatercept) for the treatment of …

News
800px-pfizer_finland_hq_february_13_2009_1

Pfizer’s Xeljanz approved by the FDA for the treatment of children with arthritis

September 29, 2020
Manufacturing and Production

The FDA has approved Pfizer’s Xeljanz (tofacitinib) for the treatment of children and adolescents with active polyarticular course juvenile idiopathic …

News
president_of_the_united_states_donald_j

Trump announces 150 million Abbott COVID-19 tests will be deployed across the US

September 29, 2020
Manufacturing and Production

President Donald Trump announced on Monday that the government will distribute 150 million coronavirus tests from Abbott Laboratories across the …

News
fda_21_4

FDA pauses the planning stages of Inovio’s late-stage COVID-19 vaccine trials

September 29, 2020
Manufacturing and Production COVID-19 vaccine, FDA, coronavirus vaccines

The FDA has put Inovio’s planning stages for the final trials of its coronavirus vaccine on hold as the regulator …

News
european_commission_web

Jyseleca secures European approval in rheumatoid arthritis

September 28, 2020
Research and Development, Sales and Marketing Europe, Jyseleca, arthritis, pharma

The European Commission has awarded approval to Gilead and Galpagos for their oral JAK inhibitor Jyseleca (filgotinib) as a treatment …

News
nasal-spray-drawing

Novel prophylactic nasal spray reduced COVID-19 replication by 96% in animal studies

September 28, 2020
Research and Development, Sales and Marketing COVID-19, Ena Respiratory, Nasal Spray

Australian biotech Ena Respiratory has revealed new data demonstrating that its novel nasal spray almost halted replication of the SARS-CoV-2 …

News
800px-glaxosmithkline_headquaters_-brentford_london_england-2oct2011

FDA approves GlaxoSmithKline’s Nucala to treat hypereosinophilic syndrome

September 28, 2020
Sales and Marketing

The FDA has announced its approval of GlaxoSmithKline’s Nucala (mepolizumab) as a treatment for hypereosinophilic syndrome (HES).  This is specifically …

News
800px-informal_meeting_of_foreign_affairs_ministers_gymnich

UK promises £500m to global vaccine sharing scheme

September 28, 2020
Sales and Marketing

UK Prime Minister Boris Johnson has announced in a speech to the UN General Assembly that the UK is set …

News
download

FDA issues a warning against Benadryl TikTok challenge

September 28, 2020
Medical Communications, Sales and Marketing Benadryl, FDA, TikTok

The FDA has released a warning following cases of teens filming themselves overdosing on the antihistamine Benadryl and uploading the …

News
shutter

Japan approves Gilead and Eisai’s Jyseleca for rheumatoid arthritis

September 25, 2020
Medical Communications, Sales and Marketing Eisai, Gilead, Japan, Jyseleca

Gilead and Eisai have secured approval for their oral JAK1 preferential inhibitor Jyseleca (filgotinib) from the Japanese Ministry of Health, …

News
shutterstock_2

GSK confirms deal to supply 300 million COVID-19 vaccine doses to the EU

September 25, 2020
Manufacturing and Production, Medical Communications COVID-19, EU, GSK, Vaccine

GlaxoSmithKline has confirmed a new COVID-19 vaccine supply deal to deliver 300 million doses of its candidate to the European …

News
donald_trump_29496131773_1

Trump approves plan to make the import of Canadian drugs easier

September 25, 2020
Medical Communications

President Trump has outlined his “America First Health Plan” on Thursday, which will allow the easy importation of prescription drugs …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026